Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

por Kee, Kwong-Ming, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan
Publicado 2014

Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival

por Kee, Kwong Ming, Wang, Jing-Houng, Wang, Chih-Chi, Cheng, Yu-Fan, Lu, Sheng-Nan
Publicado 2016

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function

por Chien, Tai-Long, Wang, Jing-Houng, Kee, Kwong-Ming, Chen, Chien-Hung, Hung, Chao-Hung, Lu, Sheng-Nan
Publicado 2016

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening

por Kuo, Yuan-Hung, Kee, Kwong-Ming, Hsu, Nien-Tzu, Wang, Jing-Houng, Hsiao, Chang-Chun, Chen, Yi, Lu, Sheng-Nan
Publicado 2019

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

por Yen, Yi-Hao, Kee, Kwong-Ming, Chen, Chien-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung
Publicado 2019

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

por Yen, Yi-Hao, Chen, Chien-Hung, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan, Kee, Kwong-Ming, Hu, Tsung-Hui
Publicado 2019

Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation

por Yeh, Wen-Shuo, Chiang, Pi-Ling, Kee, Kwong-Ming, Chang, Ching-Di, Lu, Sheng-Nan, Chen, Chien-Hung, Wang, Jing-Houng
Publicado 2020

Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community

por Kuo, Yuan-Hung, Tsai, Ming-Chao, Kee, Kwong-Ming, Chang, Kuo-Chin, Wang, Jing-Houng, Lin, Chun-Yin, Lin, Sheng-Che, Lu, Sheng-Nan
Publicado 2016

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation

por Chen, Hsin-Yeh, Lu, Sheng-Nan, Hung, Chao-Hung, Wang, Jing-Houng, Chen, Chien-Hung, Yen, Yi-Hao, Kuo, Yuan-Hung, Kee, Kwong-Ming
Publicado 2020

Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case

por Wang, Ming-Hung, Kuo, Yuan-Hung, Yen, Yi-Hao, Lu, Sheng-Nan, Wang, Jing-Houng, Chen, Chien-Hung, Hung, Chao-Hung, Kee, Kwong-Ming
Publicado 2021

SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer

por Chu, Yu-De, Kee, Kwong-Ming, Lin, Wey-Ran, Lai, Ming-Wei, Lu, Sheng-Nan, Chung, Wen-Hung, Pang, See-Tong, Yeh, Chau-Ting
Publicado 2021

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients

por Yen, Yi-Hao, Kee, Kwong-Ming, Li, Wei-Feng, Liu, Yueh-Wei, Wang, Chih-Chi, Hu, Tsung-Hui, Tsai, Ming-Chao, Lin, Chih-Yun
Publicado 2023

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology

por Yen, Yi-Hao, Kee, Kwong-Ming, Li, Wei-Feng, Liu, Yueh-Wei, Wang, Chih-Chi, Hu, Tsung-Hui, Tsai, Ming-Chao, Kuo, Yuan-Hung, Lin, Chih-Yun
Publicado 2023

Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation

por Kuo, Yuan-Hung, Huang, Tzu-Hsin, Yen, Yi-Hao, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung, Tsai, Ming-Chao, Kee, Kwong-Ming
Publicado 2023

A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort

por Yen, Yi-Hao, Kee, Kwong-Ming, Kuo, Fang-Ying, Chang, Kuo-Chin, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung
Publicado 2018

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

por Kuo, Yuan-Hung, Yen, Yi-Hao, Chen, Yen-Yang, Kee, Kwong-Ming, Hung, Chao-Hung, Lu, Sheng-Nan, Hu, Tsung-Hui, Chen, Chien-Hung, Wang, Jing-Houng
Publicado 2021

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

por Kuo, Yuan-Hung, Lu, Sheng-Nan, Chen, Yen-Yang, Kee, Kwong-Ming, Yen, Yi-Hao, Hung, Chao-Hung, Hu, Tsung-Hui, Chen, Chien-Hung, Wang, Jing-Houng
Publicado 2021

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

por Kuo, Yuan-Hung, Lu, Sheng-Nan, Chen, Yen-Yang, Kee, Kwong-Ming, Yen, Yi-Hao, Hung, Chao-Hung, Hu, Tsung-Hui, Chen, Chien-Hung, Wang, Jing-Houng
Publicado 2021

The incidence of resistance-associated variants to NS5A in HCV subtypes 1a and 1b in Taiwan

por Tsai, Ming-Chao, Hung, Chao-Hung, Lu, Sheng-Nan, Wang, Jing-Houng, Chen, Chien-Hung, Kee, Kwong-Ming, Chang, Kuo-Chin, Chao, Tsai-Ling, Hu, Tsung-Hui
Publicado 2021

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

por Yen, Yi-Hao, Kuo, Fang-Ying, Kee, Kwong-Ming, Chang, Kuo-Chin, Tsai, Ming-Chao, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung
Publicado 2018